Print this page

Leukemia Inhibitory Factor Levels after Allogeneic Transplantation.

The primary objective is to determine LIF levels in blood at various times during the transplant process.

Protocol Number: 022104
Phase: N/A
Applicable Disease Sites: Leukemia, other
Leukemia, not otherwise specified
Scope: Local
Participating Institutions:
  • Rutgers Cancer Institute of New Jersey
    • Principal Investigator
      • Amer Assal MD

For further information about clinical trials, please contact us at 732-235-7356.